Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Inetetamab HER2 Positive Advanced Breast Cancer

NCT04963608 is registered in ClinicalTrials.gov with Zhiyong Yu as lead sponsor.

NCT NCT04963608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04963608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Inetetamab HER2 Positive Advanced Breast Cancer
Lead sponsor
Zhiyong Yu
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2021
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive advanced breast cancer